The study by Narayanan and colleagues showed that exogenous treatment with irisin, given i.p. at 18 ng/mL twice a week for 3 weeks, reduced the expression of tumor necrosis factor-alpha (TNF-α) in rats with inflammatory bowel disease [52]. Here, TNF is linked to inflammatory bowel disease.